High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes
对复杂细胞表型至关重要的基因调控元件和变异体的高通量功能注释
基本信息
- 批准号:10475750
- 负责人:
- 金额:$ 223.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalBiologicalBiological AssayBiological ProcessCRISPR screenCRISPR/Cas technologyCatalogingCatalogsCell LineageCell SurvivalCellsChromatinClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplexCoupledCultured CellsDataDevelopmentDiseaseDisease ProgressionDisease susceptibilityElementsEnvironmentEnvironmental Risk FactorGene ExpressionGene Expression RegulationGene OrderGenesGenetic PolymorphismGenetic VariationGenomeGenomicsGenotype-Tissue Expression ProjectGoalsGuide RNAHepatocyteHomeostasisHumanHuman DevelopmentHuman GeneticsHuman GenomeLearningLibrariesLinkLinkage DisequilibriumMaintenanceMapsMethodsMusMuscle CellsNatural regenerationNeuronsPharmaceutical PreparationsPharmacologyPhenotypePlayPositioning AttributeProtocols documentationQuantitative Trait LociReagentRegenerative responseRegulator GenesRegulatory ElementReporterRoleShapesStimulusSuspensionsTissuesTransgenic OrganismsUndifferentiatedUntranslated RNAVariantViralViral Vectorbasecausal variantcell fate specificationcell growthcell typedata resourcedelivery vehicleepigenome editingepigenomicsfitnessgene functiongenome annotationgenome-widegenomic variationin vitro Modelin vivoinduced pluripotent stem cellmouse modelnovelpopulation basedresponsesingle-cell RNA sequencingtissue regenerationtooltraitwhole genome
项目摘要
ABSTRACT
Large scale genome annotation consortia such as ENCODE, Epigenomics Roadmap, and
others have identified millions of putative regulatory elements. We now need to focus efforts on
comprehensively characterizing and quantifying the function of those elements, and noncoding
variants that map within these regions, on gene expression and cell phenotypes. Our long-term
goal is to assign function to every regulatory element and noncoding variant in the human
genome, understand how that function changes in different contexts, and use that information to
better understand cell fitness, disease mechanisms, cell lineage specification, and tissue
homeostasis. To accomplish this goal, we have developed multiple novel high-throughput
CRISPR-based technologies for characterizing the function of putative gene regulatory
elements by perturbing their activity in their endogenous, native context. We have coupled these
methods with single-cell RNA-seq to identify the target gene(s) for each regulatory element. We
have also developed dCas9 effector mice to characterize elements in their natural in vivo
context. In addition, we have developed population-based high-throughput reporter assays
(POP-STARR) to characterize the impact of noncoding genetic variation across the entire
genome. The objective of this proposal is to apply and share our compendium of
complementary, robust, scaleable, and well-characterized methods by working collaboratively to
support the IGVF Consortium goals of understanding how genomes and genomic variation
function and orchestrate complex phenotypes. Our track record in developing, applying, and
sharing these high-throughput characterization methods, as well as providing access to all data,
supports that we will be successful in accomplishing our objective via the following specific
aims: Aim 1. Characterize all gene regulatory elements essential for cell survival. Aim 2.
Characterize all gene regulatory elements essential to cell lineage specification. Aim 3.
Characterize all gene regulatory elements in select eQTL regions. Aim 4. Characterize all non-
coding elements essential to tissue homeostasis in a mouse model. We will make all data
immediately available, as well as share comprehensive protocols, reagents, and analysis tools
to the scientific community. Together, the diverse approaches of this Characterization Center will
lead to transformative progress in understanding the role of regulatory elements and noncoding
variants across many diverse phenotypes.
抽象的
大型基因组注释联盟,例如编码,表观基因组路线图和
其他人已经确定了数百万个推定的监管要素。我们现在需要专注于
全面表征和量化这些元素的功能,而非编码
这些区域内映射的变体,基因表达和细胞表型。我们的长期
目标是将功能分配给人类的每个监管元素和非编码变体
基因组,了解该功能在不同上下文中的变化,并将这些信息使用
更好地了解细胞健身,疾病机制,细胞谱系规格和组织
稳态。为了实现这一目标,我们开发了多个新颖的高通量
基于CRISPR的技术来表征推定基因调节的功能
通过在内源性的本地环境中扰动其活性来通过元素。我们耦合了这些
具有单细胞RNA-Seq的方法可确定每个调节元件的靶基因。我们
还开发了DCAS9效应子小鼠以表征其自然体内元素
语境。此外,我们开发了基于人群的高通量记者测定法
(流行音乐)表征整个不编码遗传变异的影响
基因组。该提案的目的是申请并分享我们的汇编
通过合作,互补,健壮,可扩展性和良好的方法
支持IGVF财团的目标,以了解基因组和基因组变异
功能和编排复杂表型。我们在开发,应用和
共享这些高通量表征方法,并提供对所有数据的访问
支持我们将通过以下特定的特定来成功实现目标
目的:目标1。表征所有基因调节元件对于细胞存活所必需的。目标2。
表征所有基因调节元件对细胞谱系规范必不可少的。目标3。
表征所选eqtl区域中所有基因调节元件。目标4。表征所有非 -
在小鼠模型中对组织稳态必不可少的编码元素。我们将制作所有数据
立即可用,以及共享全面的协议,试剂和分析工具
向科学界。在一起,这个特征中心的多种方法将
导致变革性进步在理解监管要素和非编码的作用方面
许多不同表型的变体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GREGORY E CRAWFORD其他文献
GREGORY E CRAWFORD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GREGORY E CRAWFORD', 18)}}的其他基金
Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia
超越 GWAS:高通量功能基因组学
- 批准号:
10377555 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Genomics, variation, and evolution of cerebellar circuits linked to higher cognitive functions in humans
与人类高级认知功能相关的小脑回路的基因组学、变异和进化
- 批准号:
10375139 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes
对复杂细胞表型至关重要的基因调控元件和变异体的高通量功能注释
- 批准号:
10689190 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
High-Throughput Functional Annotation of Gene Regulatory Elements and Variants Critical to Complex Cellular Phenotypes
对复杂细胞表型至关重要的基因调控元件和变异体的高通量功能注释
- 批准号:
10297406 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Regulatory Mechanisms of CD4+ T Cell Differentiation
CD4 T细胞分化的调控机制
- 批准号:
10240966 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia
超越 GWAS:高通量功能基因组学
- 批准号:
10115982 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Genomics, variation, and evolution of cerebellar circuits linked to higher cognitive functions in humans
与人类高级认知功能相关的小脑回路的基因组学、变异和进化
- 批准号:
10440526 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Beyond GWAS: High Throughput Functional Genomics & Epigenome Editing to Elucidate the Effects of Genetic Associations for Schizophrenia
超越 GWAS:高通量功能基因组学
- 批准号:
10573335 - 财政年份:2021
- 资助金额:
$ 223.83万 - 项目类别:
Identifying Pathogenic Non-Coding Mutations in Rare Mendelian Disease
鉴定罕见孟德尔病的致病性非编码突变
- 批准号:
9806572 - 财政年份:2019
- 资助金额:
$ 223.83万 - 项目类别:
3/3 Chromatin regulation during brain development and in ASD
3/3 大脑发育和自闭症谱系障碍中的染色质调节
- 批准号:
9727072 - 财政年份:2018
- 资助金额:
$ 223.83万 - 项目类别:
相似国自然基金
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DGT原位测定全氟辛酸的生物污损效应及其影响机制研究
- 批准号:42207312
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
集成微流控芯片应用于高通量精准生物检体测定
- 批准号:
- 批准年份:2020
- 资助金额:60 万元
- 项目类别:面上项目
硫酸盐还原菌生物膜活性的原位快速测定研究
- 批准号:41876101
- 批准年份:2018
- 资助金额:62.0 万元
- 项目类别:面上项目
冬虫夏草抗菌肽的序列测定及其生物学功能研究
- 批准号:81803848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 223.83万 - 项目类别:
Engineered tissue arrays to streamline deimmunized DMD gene therapy vectors
工程组织阵列可简化去免疫 DMD 基因治疗载体
- 批准号:
10724882 - 财政年份:2023
- 资助金额:
$ 223.83万 - 项目类别:
Novel Polymer-antibody Conjugates as Long-acting Therapeutics for Ocular Diseases
新型聚合物-抗体缀合物作为眼部疾病的长效治疗药物
- 批准号:
10760186 - 财政年份:2023
- 资助金额:
$ 223.83万 - 项目类别:
Lung developmental defects caused by type I collagen mutations in mouse models of osteogenesis imperfecta
成骨不全小鼠模型中 I 型胶原蛋白突变引起的肺发育缺陷
- 批准号:
10735577 - 财政年份:2023
- 资助金额:
$ 223.83万 - 项目类别: